Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.
Li H, Zhang G, Jiang C, Zhang F, Ke C, Zhao H, Sun Y, Zhao M, Chen D, Zhu X, Zhang L, Li B, Dai J, Li W.
Li H, et al. Among authors: jiang c.
Oncotarget. 2015 Sep 15;6(27):24192-204. doi: 10.18632/oncotarget.4206.
Oncotarget. 2015.
PMID: 26284588
Free PMC article.